Krebs Biochemicals & Industries Limited Stock NSE India S.E.
Equities
KREBSBIO
INE268B01013
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.69 INR | +0.26% |
|
-0.56% | -9.78% |
Sales 2022 | 587M 7.04M 9.61M | Sales 2023 | 521M 6.25M 8.54M | Capitalization | 1.22B 14.58M 19.91M |
---|---|---|---|---|---|
Net income 2022 | -445M -5.33M -7.29M | Net income 2023 | -247M -2.96M -4.04M | EV / Sales 2022 | 7.71 x |
Net Debt 2022 | 1.43B 17.14M 23.41M | Net Debt 2023 | 1.83B 21.97M 30.01M | EV / Sales 2023 | 5.85 x |
P/E ratio 2022 |
-6.94
x | P/E ratio 2023 |
-4.92
x | Employees | 210 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 22.45% |
1 day | +0.26% | ||
1 week | -0.56% | ||
Current month | +14.02% | ||
1 month | +4.73% | ||
3 months | +6.06% | ||
6 months | -12.40% | ||
Current year | -9.78% |
![Extreme 69.53](/images/extremecours_fleche.png)
![Extreme 61](/images/extremecours_fleche.png)
![Extreme 60.35](/images/extremecours_fleche.png)
![Extreme 60.35](/images/extremecours_fleche.png)
![Extreme 50.65](/images/extremecours_fleche.png)
![Extreme 50.65](/images/extremecours_fleche.png)
![Extreme 50.65](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Jitendra Shah
CEO | Chief Executive Officer | - | 21-11-08 |
Founder | 74 | 91-12-01 | |
Ritesh Jain
DFI | Director of Finance/CFO | - | 23-02-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 00-09-25 | |
Founder | 74 | 91-12-01 | |
Avinash Ravi
BRD | Director/Board Member | 45 | 01-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-25 | 70.69 | +0.26% | 25,840 |
24-06-24 | 70.51 | -1.14% | 16,785 |
24-06-21 | 71.32 | -2.27% | 12,993 |
24-06-20 | 72.98 | +1.26% | 33,991 |
24-06-19 | 72.07 | +1.38% | 8,828 |
Delayed Quote NSE India S.E., June 25, 2024 at 07:43 am
More quotes1st Jan change | Capi. | |
---|---|---|
+19.51% | 42.97B | |
+27.49% | 22.16B | |
+19.29% | 15.45B | |
+20.33% | 14.56B | |
+55.51% | 13.03B | |
-0.05% | 6.79B | |
-11.37% | 6.46B | |
+17.73% | 5.87B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- KREBSBIO Stock
- KREBSBIO Stock